Search - tctmd.com

Displaying 901 - 920 of 1898

Sort: Relevancy | Date

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

Presentation TCT 2014

COREVALVE Pivotal Trials: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Jeffrey J. Popma

September 13, 2014

Presentation TCT 2014

CHOICE: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Mohamed Abdel-Wahab

September 13, 2014

Presentation TCT 2014

EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Philippe Gabriel Steg

September 13, 2014

Presentation TCT 2014

HEAT: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Rod H. Stables

September 13, 2014

Presentation TCT 2014

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Daniele Giacoppo, MD

September 13, 2014

Presentation TCT 2014

How to Be a Key Enroller in Clinical Trials: Building the Team!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, James C. Blankenship

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Conference News TCT 2014

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

September 13, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

Advertisement

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

ABSORB EXTEND: BVS Safe Out to 3 Years

COREVALVE Pivotal Trials: Core Results and Study Group Interpretation

CHOICE: Core Results and Study Group Interpretation

EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation

HEAT: Core Results and Study Group Interpretation

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

How to Be a Key Enroller in Clinical Trials: Building the Team!

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

COMPARE II: BES, EES Show Similar Outcomes at Three Years

European Societies Release Updated Revascularization Guidelines for CAD

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content